The Warsaw team of Taylor Wessing provided comprehensive legal advice to BioMaxima S.A. in connection with the transfer of the company’s listing from NewConnect to the main trading floor of the Warsaw Stock Exchange. It was the first debut on the WSE’s main market in 2022.
Taylor Wessing’s advice included drafting the legal part and coordinating all work on the prospectus, as well as legal advice related to the admission and introduction of the shares to trading on the WSE’s main market.
The project was led by partner Jakub Pitera, Ph.D., supported by Patrycja Sojka (Associate). The interdisciplinary team consisted of: in the area of life sciences law: Agnieszka Sztoldman, Ph.D. (Senior Associate); in the area of employment law: partner Krystian Stanasiuk, supported by Michał Zabost (Associate); in the area of commercial law: Marta Janowska (Senior Associate), and in the area of tax issues: of Counsel Marcin Zimny.
“We are proud of the trust that BioMaxima S.A. has placed in us in such a strategic development decision as the move to the main market of the WSE. As lawyers, we are happy to support our clients in their development, particularly in the life sciences sector, where we have many years of market-leading experience,” said Dr Pitera.
BioMaxima S.A. is a Polish manufacturer of microbiological media, reagents and equipment for in vitro diagnostics, including SARS-CoV-2 tests. It also distributes products of global diagnostic companies. Its customers include companies operating in the laboratory, veterinary and industrial medicine markets. It supplies products to over 2,000 laboratories in Poland and exports them to over 60 markets worldwide. It has been present on the NewConnect market since 2010.
